Advanced search×

Welcome to the Pubget Medical Subject Headings (MeSH) browser.

Click on a topic or subtopic below to explore related papers. You'll find the most recent paper about the current MeSH term along with other related papers below.

All › Neoplasms › Neoplasms by Site › Thoracic Neoplasms › Respiratory Tract Neoplasms › Pleural Neoplasms › Pleural Effusion, Malignant

Pleural Effusion, Malignant (0)

      Articles on Pleural Effusion, Malignant

      1. Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the ...
        Guénaëlle G Levallet, Mélissa M Vaisse-Lesteven, ... Francoise F Galateau-Sallé

        J Thorac Oncol 7(3):599-606 (2012) PMID 22246193

        We showed the physiological relevance of phospho-c-MET nuclear translocation. Our results lighten that, disregarding the intracellular c-MET receptor traffic, only c-MET plasma membrane localization could be a relevant prognosis biomarker in malignant pleural mesothelioma. Whether pa...
      2. Detection of alveolar rhabdomyosarcoma in pleural fluid with immunocytochemistry on cell block and determination of PAX/FKHR fusion mRNA by ...
        Ruchchadol R Sawangpanich, Noppadol N Larbcharoensub, ... Suradej S Hongeng

        J Med Assoc Thai 94(11):1394-8 (2011) PMID 22256481

        Alveolar rhabdomyosarcoma is a primitive malignant round cell neoplasm, which shows skeletal muscle differentiation. Although their histopathologic and immunohistochemical findings are well known, the cytology, immunocytochemistry and molecular study on pleural effusion have not been...
      3. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: a patient successfully treated with pleurodesis.
        Tao T Wang, Victor E VE Nava, ... Min-Ling ML Liu

        J Clin Oncol 29(29):e747-50 (2011) PMID 21810684

      4. [Establishment of primary Her-2 over- expression human breast cancer cell model].
        Li-juan LJ Wang, Yue Y Zhao, ... Qing Q Zhu

        Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(10):1148-50 (2011) PMID 22238824

        Through isolation and purification pri-mary HER2 overexpression human breast cancer cells from malignant pleural effusion and identification the HER2 expression level of the cells to establish the primary HER2 overexpression human breast cancer cell model. METH-ODS: Malignant pleural...
      5. Myelomatous pleural effusion: a case series in a single institution and literature review.
        Young-Uk YU Cho, Hyun-Sook HS Chi, ... Cheolwon C Suh

        Korean J Lab Med 31(4):225-30 (2011) PMID 22016674 PMCID PMC3189999

        We present a consecutive series of patients with MPE in a single institution. We retrospectively reviewed the medical records of 19 patients diagnosed with MPE between 1989 and 2008 at the Asan Medical Center. Diagnoses were confirmed by cytologic identification of malignant plasma c...
        View PDF
      6. Acute myeloid leukemia with myelodysplasia-related changes with erythroid differentiation involving pleural fluid: a case report and brief c...
        Lisa Marie Stoll, Amy S Duffield, ... Syed Z Ali

        Diagn Cytopathol 39(6):451-4 (2011) PMID 20954271

        We report a rare case of a 54-year-old male with a prior diagnosis of acute myeloid leukemia with myelodysplastic-related changes (AML-MDS) with erythroid differentiation having new onset pleural effusions containing leukemic blasts. The pleural specimen was comprised of blast forms having large rou...
      7. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in ...
        Katsuhide K Ikeda, Genshu G Tate, ... Toshiyuki T Mitsuya

        Diagn Cytopathol 39(6):395-401 (2011) PMID 21574259

        To differentiate reactive mesothelial cells (RMs) from metastatic carcinoma and malignant mesothelioma (MM) in effusion cytology is crucial for the cytologic diagnosis and the management of the patients. In the present study, the immunocytochemical staining profile of the epithelial...
      8. Thoracoscopic assessment of pleural tumor burden in patients with malignant pleural effusion: prognostic and therapeutic implications.
        Lama L Sakr, Fabien F Maldonado, ... Philippe P Astoul

        J Thorac Oncol 6(3):592-7 (2011) PMID 21258256

        Malignant pleural effusion (MPE) is encountered at an advanced stage of disease progression and often heralds a poor prognosis. The most reliable predictive factor of survival in such patients is the primary tumor. Thoracoscopy is often performed for accurate diagnosis and/or thoraco...
      9. Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesothelioma.
        Hidekazu Suzuki, Tomonori Hirashima, ... Ichiro Kawase

        Anticancer Res 30(10):4343-6 (2010) PMID 21036761

        The clinical utility of tumour markers in pleural effusion is still controversial with regard to the efficient detection of malignant pleural mesothelioma (MPM). The levels of carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21-1) were retrospectively studied in pleural effusion of...
      10. Prognostic factors for survival after surgical palliation of malignant pleural effusion.
        John E Pilling, Michael E Dusmet, ... Peter Goldstraw

        J Thorac Oncol 5(10):1544-50 (2010) PMID 20802350